Terminally differentiated, antibody-secreting plasma cells are the end-stage effectors of humoral immune responses. Although the overproduction of immunoglobulins by short-lived plasma cells accompanying an immune response links with their apoptosis, how long-lived plasma cells adapt to ensure their longevity in this context is obscure. Dr. Lin's laboratory showes that apoptosis signal-regulating kinase 1 (ASK1) contributes to apoptosis of plasma cells. Antigen-specific long-lived plasma cells generated by immunization accumulated in ASK1-deficient mice. Enforced expression of ASK1 in malignant plasma cells, multiple myeloma (MM), caused apoptosis in vitro and lowered MM load in a xenograft animal model. Additionally, a critical survival-related transcriptional repressor, Blimp-1, is crucial for silencing ASK1 in maintaining the survival of plasma cells. Our findings not only reveal a novel mechanism underlying the regulation of survival in normal and malignant plasma cells by ASK1 but also provide a new therapeutic insight into plasma cell diseases.
